We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. By combining data on recurrent gene mutations (BIRC3, MYD88, NOTCH1, SF3B1 and TP53) and cytogenetic aberrations, we reveal a subset-biased acquisition of gene mutations. More specifically, the frequency of NOTCH1 mutations was found to be enriched in subsets expressing unmutated immunoglobulin genes, i.e. #1, #6, #8 and #59 (22-34%), often in association with trisomy 12, and was significantly different (P<0.001) to the frequency observed in subset #2 (4%, aggressive disease, variable somatic hyp...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Chronic lymphocytic leukemia (CLL) exhibits remarkable clinical heterogeneity likely reflecting the ...
Highly homologous B-cell receptors, characterized by non-random combinations of immunoglobulin heavy...
on behalf of ERIC, the European Research Initiative on CLLInternational audienceWe report on markedl...
We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
In recent years, the genetic landscape of B-cell derived lymphoid malignancies, including chronic ly...
Recent studies have revealed recurrent mutations of the NOTCH1, SF3B1 and BIRC3 genes in chronic lym...
Background The existence of multiple subsets of chronic lymphocytic leukemia expressing ‘stereotyped...
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to ...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Chronic lymphocytic leukemia (CLL) exhibits remarkable clinical heterogeneity likely reflecting the ...
Highly homologous B-cell receptors, characterized by non-random combinations of immunoglobulin heavy...
on behalf of ERIC, the European Research Initiative on CLLInternational audienceWe report on markedl...
We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
In recent years, the genetic landscape of B-cell derived lymphoid malignancies, including chronic ly...
Recent studies have revealed recurrent mutations of the NOTCH1, SF3B1 and BIRC3 genes in chronic lym...
Background The existence of multiple subsets of chronic lymphocytic leukemia expressing ‘stereotyped...
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to ...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Chronic lymphocytic leukemia (CLL) exhibits remarkable clinical heterogeneity likely reflecting the ...
Highly homologous B-cell receptors, characterized by non-random combinations of immunoglobulin heavy...